Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Amyloidosis].

E C Franklin

    Fortschritte Der Medizin
    |May 26, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Amyloidosis involves various substances with beta-pleated sheets. Colchicine shows promise for treating amyloidosis, particularly in Familial Mediterranean Fever.

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Temporal and spatial trends in prey composition of wahoo Acanthocybium solandri: a diet analysis from the central North Pacific Ocean using visual and DNA bar-coding techniques.

    Journal of fish biology·2016
    Same author

    Two antigenically distinguishable subclasses of human A myeloma proteins differing in their heavy chains.

    Nature·2010
    Same author

    ANTIGENIC RELATIONSHIPS BETWEEN IMMUNE GLOBULINS AND CERTAIN RELATED PARAPROTEINS IN MAN.

    The Journal of experimental medicine·2009
    Same author

    Preferential association of kappa IIIb light chains with monoclonal human IgM kappa autoantibodies.

    Journal of immunology (Baltimore, Md. : 1950)·1983
    Same author

    Characterization of amyloid deposits and P component from a patient with factor X deficiency reveals proteins derived from a lambda VI light chain.

    The American journal of medicine·1983
    Same author

    Identification of elastases associated with purified plasma membranes isolated from human monocytes and lymphocytes.

    Biochimica et biophysica acta·1983
    Same journal

    [More information--less pain. Procedure in pain following amputation of limbs. Brachial plexus injury and nerve root avulsion. Interview by Susanne Kammerer].

    Fortschritte der Medizin·1999
    Same journal

    [Galenic alternatives to unstable tocopherol acetate. "Smeared" or cheated?--Vitamin E in facial ointments].

    Fortschritte der Medizin·1999
    Same journal

    [Gene diagnosis in the hand of the physician].

    Fortschritte der Medizin·1999
    Same journal

    [Is non-toxic cancer therapy through biotechnology a possibility?].

    Fortschritte der Medizin·1999
    Same journal

    [Smoking withdrawal in practice and clinic].

    Fortschritte der Medizin·1999
    Same journal

    [The future of pancreas diagnosis. An exclusive training service of the Gastro-Ligue for dermatologists].

    Fortschritte der Medizin·1999
    See all related articles

    Area of Science:

    • Biochemistry
    • Pathology
    • Microscopy

    Context:

    • Amyloid is a diverse group of substances sharing beta-pleated sheet structures.
    • Common amyloid types include immunoglobulin light chain (AL) and AA protein.
    • Localized amyloidosis may involve prohormones or tissue proteins.

    Purpose:

    • To review the diverse nature of amyloid and its precursors.
    • To discuss the origins of systemic amyloidosis (AL and AA types).
    • To evaluate colchicine as a potential therapeutic agent for amyloidosis.

    Summary:

    • Amyloidosis encompasses various proteins with a shared beta-pleated sheet structure.
    • Systemic amyloidosis fibrils originate from circulating precursors like immunoglobulin light chains (AL) and SAA protein (AA).
    • The exact cause (overproduction vs. degradation defect) remains unknown.

    Impact:

    • Colchicine has demonstrated efficacy in Familial Mediterranean Fever and experimental amyloidosis.
    • Further research into colchicine for other amyloidosis types is warranted.
    • Understanding amyloid composition is crucial for developing targeted therapies.